Immunomax - Crunchbase Company Profile & Funding

Q: Who invested in Immunomax?

Immunomax is funded by UTC Investment Co..

Q: When was the last funding round for Immunomax?

Immunomax closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Immunomax

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Immunomax

CB Rank

2309172

Immunomax is a biotechnology company that specializes in immunology-based biopharmaceuticals.

Founded

obfuscation

Private

Venture - Series Unknown

Seoul, Seoul-t'ukpyolsi, South Korea

immunomax.co.kr

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Details

Also Known As

이뮤노맥스

Operating Status

Active

Company Type

For Profit

About the Company

Immunomax is a biotechnology company that specializes in immunology-based biopharmaceuticals. The company develops allogeneic gamma delta CAR-T cell therapies and animal cell lines for high-efficiency biopharmaceutical production.

Phone Number

02-6946-8700

Contact Email

info@immunomax.co.kr

Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Immunomax	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
UTC Investment Co.	—	Venture Round - Immunomax	—
UTC Investment Co.	—	Venture Round - Immunomax	—
UTC Investment Co.	—	Venture Round - Immunomax	—
UTC Investment Co.	—	Venture Round - Immunomax	—
UTC Investment Co.	—	Venture Round - Immunomax	—